| Description | Numerator | Denominator | Target Percentage |
|---|---|---|---|
| Clinical Management of Hypertension | Number of hypertensive patients on medication evaluated this reporting quarter with a blood pressure reading of less <140/< 90 millimeters of mercury | Number of patients being treated for hypertension with medication, for a minimum of 6 months, who are evaluated this reporting quarter | 2004 - 70% 2005 – 70% 2006 – 70% 2007 – 70% |
| Clinical Management of Lipid Level | Number of patients on lipid reduction medication, with a history of cardiovascular risk or two cardiac risk factors, with a low density lipoprotein level < 100 milligrams reported this reporting quarter | Number of patients on lipid reduction medication for a minimum of 6 months, who have lipids measured this reporting quarter and meet requirements listed in the numerator statement | 2004 - 65% 2005 – 50% 2006 – 50% 2007 – 65% |
| Clinical Management of Diabetes – HbA1C Level | Number of diabetic patients on insulin or oral medication with an HbA1C level measured 8% or less, as a result of a test this reporting quarter | Number of diabetic patients on insulin or oral medication for a minimum of 6 months with HbA1C level measured this reporting quarter | 2004 - 65% 2005 – 65% 2006 – 65% 2007 – 65% |
| Clinical Management of HIV/ Ribonucleic Acid Level | Number of inmates on antiretroviral therapy with HIV/ Ribonucleic Acid levels < 50 cps/ml, as confirmed by ultra-sensitive method this reporting quarter | Number of inmates on antiretroviral therapy with known HIV/ Ribonucleic Acid standard level of < 400 cps/ml who have had the ultra-sensitive method test this reporting quarter < 50 cps/ml, as confirmed by ultra-sensitive method this reporting quarter | 2004 - 60% 2005 – 60% 2006 – 60% 2007 – 85% |
| Completion of Isoniazid Treatment | Number of inmates on treatment for Latent Tuberculosis Infection who have completed bi-weekly isoniazid therapy during this reporting quarter | Number of inmates previously started on treatment for Latent Tuberculosis Infection who should have completed treatment within this reporting quarter | 2005 – 90% 2006 – 90% 2007 – 90% |
| Asthma-related Hospitalization or Mortality | Number of patients diagnosed with asthma, who are taking chronic asthma medication, and who were not hospitalized, or did not expire from asthma this reporting quarter | Number of patients diagnosed with asthma, who are taking chronic asthma medication, and who were in the institution this reporting quarter | 2005 – 100% 2006 – 100% 2007 – 98% |
| Breast Cancer Screening | Number of females screened by mammography this reporting period | Number of females who require mammography screening this reporting period | 2004 - 50% 2005 – 50% 2006 – 50% 2007 – 50% |
| Cervical Cancer Screening | Number of female patients who received screening by PAP this reporting period | Number of female patients who would require screening by PAP | 2004 - 50% 2005 – 50% 2006 – 50% 2007 – 50% |
| Pregnancy Testing at Intake | Number of new intake females tested for pregnancy this reporting period | Number of new female intakes (pre-menopausal) arriving in the institution this reporting period | 2004 - 90% 2005 – 90% 2006 – 90% 2007 – 90% |